A new research paper was published in Oncotarget titled, "Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling ...
Jul 9, 2024
0
0
A new approach to treating the most malignant type of brain cancer—glioblastoma—has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates beyond 18 months.
Jul 9, 2024
0
1
To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy.
Jul 8, 2024
0
34
Published today in Cancer Cell, results of a study directed by Joaquin Mateo, Head of the Vall d'Hebron Institute of Oncology's (VHIO) Prostate Cancer Translational Research Group, show that DNA/RNA material contained in ...
Jul 8, 2024
0
24
Researchers at Dana-Farber Cancer Institute, in collaboration with colleagues from Memorial Sloan Kettering Cancer Center in New York (Dr. Kai Rejeski) and the LMU Hospital in Munich, Germany (Dr. Tobias Tix), have found ...
Jul 8, 2024
0
6
Research led by the Cancer Biology Laboratory of the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University, in collaboration with the Center for Genomic Regulation and the Murcian Institute of Biosanitary ...
Jul 8, 2024
0
4
A study published in the journal Protein & Cell includes an introduction to the significance of breast cancer, particularly TNBC, and the role of post-translational modifications such as arginine methylation. The study details ...
Jul 8, 2024
0
0
The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun".
Jul 5, 2024
0
67
Researchers at the Francis Crick Institute have mapped all the possible outcomes of changes to a tumor-suppressing gene called VHL, the first step in a huge research endeavor to unpick the outcomes of tens of thousands of ...
Jul 5, 2024
0
26
Cancer's resistance to chemotherapy could be reversed by targeting lactate—the product that builds up as cancer cells convert nutrients to energy, according to new research published in Nature.
Jul 4, 2024
0
31
